The Tenth Circuit Just Revived the “Natural” Cigarette Class Action — and Rule 23’s Front Door Is Wide Open Again

A Resurrection in the Rockies

For a brief moment, the consumer class action bar had written off the “safer cigarette” theory as dead on arrival. District courts had grown skeptical, predominance arguments had found traction with defense counsel, and the notion that millions of smokers could band together over subjective interpretations of “natural” and “additive-free” seemed destined for the Rule 23 graveyard. Then came the Tenth Circuit.

In a divided July 29 decision, a panel of the U.S. Court of Appeals for the Tenth Circuit breathed new life into sprawling class-action litigation against British American Tobacco’s U.S. subsidiaries, including Reynolds American and Santa Fe Natural Tobacco. The court didn’t merely tinker around the edges—it reversed a prior denial of certification on the core “safer cigarette” misrepresentation theory and upheld certification of menthol-related claims, effectively expanding the battlefield on which this war will be fought.

The dissent, penned by a Republican-appointed judge, didn’t just disagree. It sounded the alarm, suggesting the case “likely warrants Supreme Court review.” When a federal appellate judge writes those words, defense counsel starts drafting cert petitions before the ink dries.

The Certification Rubber Stamp? Not Quite.

Let’s be clear about what happened here. The district court had drawn a line: menthol claims could proceed as a class, but the broader theory—that “Natural American Spirit” labeling deceived consumers into believing these cigarettes were safer than competitors—could not satisfy Rule 23(b)(3)’s predominance requirement. The Tenth Circuit erased that line.

This matters because it signals a potential retreat from the rigorous analysis that Comcast Corp. v. Behrend, 569 U.S. 27 (2013), demanded. In Comcast, the Supreme Court made clear that plaintiffs must prove damages are measurable on a classwide basis through a common methodology. The Tenth Circuit’s willingness to certify the “safer cigarette” theory suggests the panel found sufficient commonality in how consumers interpreted the “natural” and “additive-free” messaging—despite obvious individual variations in smoking behavior, brand loyalty, and health awareness.

The practical effect? Plaintiffs’ counsel in consumer-fraud labeling cases just got a powerful new arrow in their quiver. If a divided appellate panel will certify a class based on allegedly misleading safety implications in cigarette marketing—where individual reliance and damages vary wildly—what does that mean for food labeling cases? For “clean beauty” claims? For the entire universe of products marketed with health halos?

The Preemption Elephant in the Room

What makes this case particularly cert-worthy isn’t just the Rule 23 expansion—it’s the lurking federal preemption question that the majority apparently sidestepped. The Federal Cigarette Labeling and Advertising Act, 15 U.S.C. § 1331 et seq., expressly preempts state-law “requirement[s] or prohibition[s] . . . imposed under State law” regarding smoking and health “with respect to advertising or promotion.”

The Supreme Court grappled with this in Cipollone v. Liggett Group, Inc., 505 U.S. 504 (1992), and more recently in Altria Group, Inc. v. Good, 555 U.S. 70 (2008), where the Court held that the Labeling Act did not preempt state-law fraud claims based on false statements of fact. But Altria involved “light” cigarette claims under a different statutory regime. Whether “natural” and “additive-free” claims—terms that arguably fall within the FDA’s regulatory purview under the Family Smoking Prevention and Tobacco Control Act—can form the basis of a state-law class action without running afoul of preemption is a question the Tenth Circuit majority seemingly treated as secondary to the certification analysis.

That’s backwards. If the claims are preempted, certification is irrelevant. The dissent’s call for Supreme Court review likely rests on this tension: can plaintiffs use state consumer-protection statutes to litigate what is essentially a disagreement with federal tobacco regulatory policy?

What Changes in Practice

For defense counsel, the immediate takeaway is that Rule 23(f) interlocutory appeals just became more critical in the Tenth Circuit. If you’re facing a consumer-fraud class certification order in the district court, you now have appellate precedent suggesting that even highly individualized reliance theories can survive certification if framed as common misrepresentations about product safety.

For plaintiffs’ lawyers, this decision opens the door to refiling theories that had been abandoned post-Comcast. The key will be framing: don’t sue over “health benefits” (too individualized); sue over “safety misrepresentations” that create a common inference of deception across the class.

But the real action is yet to come. With a dissent explicitly inviting Supreme Court review, and with the current Court’s demonstrated skepticism of expansive class certification in cases like TransUnion LLC v. Ramirez, 594 U.S. 413 (2021), this case has all the markings of a future docket entry. If the Justices grant cert, we could see a fundamental recalibration of how predominance applies to consumer-fraud claims involving regulated products.

Until then, the message to corporate America is uncomfortable: in the Tenth Circuit, at least, “natural” doesn’t mean safe from class certification.